Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/172268
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Katagiri, Yuki | - |
dc.contributor.author | Onuma, Yoshinobu | - |
dc.contributor.author | Asano, Taku | - |
dc.contributor.author | Iñiguez Romo, Andres | - |
dc.contributor.author | Jensen, Lisette Okkels | - |
dc.contributor.author | Cequier Fillat, Àngel R. | - |
dc.contributor.author | Hofma, Sjoerd H. | - |
dc.contributor.author | Christiansen, Evald H. | - |
dc.contributor.author | Suttorp, Maarten | - |
dc.contributor.author | Brugaletta, Salvatore | - |
dc.contributor.author | Räber, Lorenz | - |
dc.contributor.author | Sabaté Tenas, Manuel | - |
dc.contributor.author | Windecker, Stephan | - |
dc.contributor.author | Serruys, Patrick W. | - |
dc.date.accessioned | 2020-11-23T09:29:30Z | - |
dc.date.issued | 2018-12-07 | - |
dc.identifier.issn | 1774-024X | - |
dc.identifier.uri | http://hdl.handle.net/2445/172268 | - |
dc.description.abstract | Previous midterm follow-up reports after implantation of the Absorb everolimus-eluting bioresorbable scaffold (BRS; Abbott Vascular, Santa Clara, CA, USA) in stable coronary artery disease and acute coronary syndrome have shown an increase of scaffold thrombosis leading to an excess of the device-oriented composite endpoint (DOCE: a composite of cardiac death, target vessel myocardial infarction [TVMI], and clinically driven target lesion revascularisation [CD-TLR])1. In contrast, in the six-month primary report of ABSORB STEMI: the TROFI II Study (NCT01986803)2, which randomised patients with ST-elevation myocardial infarction (STEMI) to receive either the Absorb BRS or the XIENCE metallic everolimus-eluting stent (EES; Abbott Vascular), optical frequency domain imaging (OFDI)-derived healing score was comparable between the BRS arm and the EES arm. The aim of this report was to present the three-year clinical outcome results of the BRS and the metallic EES at the time when full resorption of the scaffold device can be expected. | - |
dc.format.extent | 1 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | EuroPCR and the European Association of Percutaneous Cardiovascular Interventions | - |
dc.relation.isformatof | https://doi.org/10.4244/EIJ-D-18-00839 | - |
dc.relation.ispartof | Eurointervention, 2018, vol. 14, num. 11, p. e1224-e1226 | - |
dc.relation.uri | https://doi.org/10.4244/EIJ-D-18-00839 | - |
dc.rights | (c) EuroPCR and the European Association of Percutaneous Cardiovascular Interventions, 2018 | - |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Malalties coronàries | - |
dc.subject.classification | Infart de miocardi | - |
dc.subject.other | Coronary diseases | - |
dc.subject.other | Myocardial infarction | - |
dc.title | Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial) | - |
dc.type | info:eu-repo/semantics/article | - |
dc.identifier.idgrec | 684614 | - |
dc.date.updated | 2020-11-23T09:29:30Z | - |
dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | - |
dc.embargo.lift | 2099-01-01 | - |
dc.date.embargoEndDate | info:eu-repo/date/embargoEnd/2099-01-01 | - |
dc.identifier.pmid | 30398967 | - |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
684614.pdf | 926.11 kB | Adobe PDF | View/Open Request a copy |
Document embargat fins el 1-1-2099
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.